https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Tue, 12 Oct 2021 15:16:42 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/w_-zxokavpg-adaptimmune-spear-t-cells/ Tue, 03 Nov 2020 17:39:49 +0000 http://13.40.107.223/video/w_-zxokavpg-adaptimmune-spear-t-cells/ TCR T-cell therapies (SPEAR T-cells) hold the potential to treat a wide range of cancers. In this video, Helen Tayton-Martin, Chief Business Officer, Adaptimmune, Oxford, UK. discusses the SPEAR T-cells currently under development with Adaptimmune. Dr Taytor-Martin goes on to discuss Adaptimmune’s partnership with GlaxoSmithKline (GSK) and recent advances such as the SURPASS trial (NCT04044859) which investigated ADP-A2M4CD8 in HLA-A2+ subjects with MAGE-A4 positive tumors. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/inpcy5nwula-t-cells-challenges-in-bringing-to-market/ Tue, 03 Nov 2020 17:39:49 +0000 http://13.40.107.223/video/inpcy5nwula-t-cells-challenges-in-bringing-to-market/ T-cell therapies present a whole host of challenges with regards to manufacturing, distribution and ultimately bringing into a clinical setting. Helen Tayton-Martin, PhD, Adaptimmune, Oxford, UK, talks on the challenges in bringing to market and how Adaptimmune has taken action to circumvent these bottlenecks. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/ltzh6fpqszc-the-cell-therapy-landscape-disruptive-technologies/ Tue, 03 Nov 2020 17:39:49 +0000 http://13.40.107.223/video/ltzh6fpqszc-the-cell-therapy-landscape-disruptive-technologies/ Helen Tayton-Martin, PhD, Adaptimmune, Oxford, UK, discusses disruptive technologies that may change the cell therapy landscape. Specifically discussed is the formation of an off-the-shelf T-cell product able to treat solid tumors with the same potency and efficacy seen with current cellular therapies. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/35iakj8nt2m-the-potential-of-regenmed-in-the-oncology-space/ Tue, 03 Nov 2020 17:39:49 +0000 http://13.40.107.223/video/35iakj8nt2m-the-potential-of-regenmed-in-the-oncology-space/ Helen Tayton-Martin, PhD, Adaptimmune, Oxford, UK, speaks on the reformative nature of regenerative medicine. Dr Taytor-Martin highlights cell and gene therapies in the oncology setting, and how these technologies may represent a potential paradigm shift in the future. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/rdmlw43ucwm-progress-in-the-face-of-covid-19/ Fri, 09 Oct 2020 16:47:09 +0000 http://13.40.107.223/video/rdmlw43ucwm-progress-in-the-face-of-covid-19/ Coronavirus has impacted almost all industries. Despite this, the regenerative medicine (RegenMed) sector has shown to be incredibly resilient. Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), Washington, DC, talks on COVID-19, and some of the issues that have arisen for RegenMed as well as positive adaptations that may remain. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/kqkg8ycjmnu-meeting-on-the-mesa-2020-goes-virtual/ Fri, 09 Oct 2020 16:47:09 +0000 http://13.40.107.223/video/kqkg8ycjmnu-meeting-on-the-mesa-2020-goes-virtual/ The Cell & Gene Meeting on the Mesa is a key annual conference for the regenerative sector, bringing together key players in both industry and academia to further advances and cutting-edge research. Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), San Francisco, CA, discusses the meeting and the move to a virtual platform in light of the COVID-19 pandemic. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/cbnk-ss1f2k-key-themes-and-discussions-at-meeting-on-the-mesa-2020/ Fri, 09 Oct 2020 16:47:09 +0000 http://13.40.107.223/video/cbnk-ss1f2k-key-themes-and-discussions-at-meeting-on-the-mesa-2020/ Janet Lambert, MBA, Alliance for Regenerative Medicine (ARM), Washington, DC, outlines the key themes and discussions that will be presented at the 2020 Meeting on the Mesa. Such insights include the realities of bringing gene therapies to market, the technologies that will disrupt cell therapy, cell and gene therapies for chronic conditions, and a special session on the challenges related to commercialization. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/xjjerxfvklq-introducing-arm-the-alliance-for-regenerative-medicine/ Fri, 09 Oct 2020 16:47:09 +0000 http://13.40.107.223/video/xjjerxfvklq-introducing-arm-the-alliance-for-regenerative-medicine/ The Alliance for Regenerative Medicine (ARM) is the only organization focussed solely on the issues facing regenerative medicine. In this video, Janet Lambert, CEO, the Alliance for Regenerative Medicine (ARM), Washington, DC, talks on the goals of ARM, with the key aim being to deliver safe and effective cell & gene therapies and tissue-engineered products to patients. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/otki-pkdcbc-challenges-facing-the-regenmed-sector-in-2020/ Fri, 09 Oct 2020 16:47:09 +0000 http://13.40.107.223/video/otki-pkdcbc-challenges-facing-the-regenmed-sector-in-2020/ Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM), Washington, DC, touches on the various barriers that currently challenge the rich and exciting regenerative medicine field. Such challenges include manufacturing, regulatory issues, and the reimbursement models currently in place. This interview took place during the 2020 Meeting on the Mesa congress.

]]> https://mirror.vjregenmed.com/video/ptodikp-g7y-putting-the-patient-first-in-regenerative-medicine/ Fri, 09 Oct 2020 16:47:09 +0000 http://13.40.107.223/video/ptodikp-g7y-putting-the-patient-first-in-regenerative-medicine/ Regenerative medicine is transforming the patient experience with innovative therapies. Paige Bischoff, Senior VP, Alliance for Regenerative Medicine (ARM), Washington, DC, discusses the importance of the patient’s voice, and the impact these therapies are having on people. This interview took place during the 2020 Meeting on the Mesa congress.

]]>